1. Home
  2. YOTA vs LTRN Comparison

YOTA vs LTRN Comparison

Compare YOTA & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YOTA
  • LTRN
  • Stock Information
  • Founded
  • YOTA 2021
  • LTRN 2013
  • Country
  • YOTA United States
  • LTRN United States
  • Employees
  • YOTA N/A
  • LTRN N/A
  • Industry
  • YOTA Farming/Seeds/Milling
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • YOTA Consumer Staples
  • LTRN Health Care
  • Exchange
  • YOTA Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • YOTA 43.9M
  • LTRN 36.2M
  • IPO Year
  • YOTA 2022
  • LTRN 2020
  • Fundamental
  • Price
  • YOTA $11.25
  • LTRN $2.95
  • Analyst Decision
  • YOTA
  • LTRN Hold
  • Analyst Count
  • YOTA 0
  • LTRN 1
  • Target Price
  • YOTA N/A
  • LTRN N/A
  • AVG Volume (30 Days)
  • YOTA 1.3K
  • LTRN 50.0K
  • Earning Date
  • YOTA 01-01-0001
  • LTRN 11-07-2024
  • Dividend Yield
  • YOTA N/A
  • LTRN N/A
  • EPS Growth
  • YOTA 35.55
  • LTRN N/A
  • EPS
  • YOTA 0.13
  • LTRN N/A
  • Revenue
  • YOTA N/A
  • LTRN N/A
  • Revenue This Year
  • YOTA N/A
  • LTRN N/A
  • Revenue Next Year
  • YOTA N/A
  • LTRN N/A
  • P/E Ratio
  • YOTA $85.06
  • LTRN N/A
  • Revenue Growth
  • YOTA N/A
  • LTRN N/A
  • 52 Week Low
  • YOTA $10.35
  • LTRN $2.79
  • 52 Week High
  • YOTA $15.49
  • LTRN $11.99
  • Technical
  • Relative Strength Index (RSI)
  • YOTA 72.10
  • LTRN 36.73
  • Support Level
  • YOTA $11.17
  • LTRN $3.04
  • Resistance Level
  • YOTA $11.23
  • LTRN $3.57
  • Average True Range (ATR)
  • YOTA 0.03
  • LTRN 0.25
  • MACD
  • YOTA 0.01
  • LTRN -0.05
  • Stochastic Oscillator
  • YOTA 100.00
  • LTRN 14.81

About YOTA Yotta Acquisition Corporation

Yotta Acquisition Corp is a shell company.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: